Avandia Side Effects That Created This Problem

For a few years after Avandia hit the market, it dominated the world of diabetes medication.  Its recent high point came in 2006 when sales of Avandia generated approximately $2.5 billion in revenue for GlaxoSmithKline.  Avandia was seen as an innovative medication that helped people control their diabetes, but troubling reports of Avandia side effects soon began to surface.  These Avandia side effects were seen as severe and potentially life threatening, and they included increased risks of heart attacks and strokes.

 

Why an Avandia Recall is Being Considered

After these reports of Avandia side effect surfaced, officials began to analyze the safety of the drug in several ways.  One of the studies initiated is known as TIDE, which is basically a comparison study between Avandia and Actos, a different diabetes drug that to date has not been linked to the same problems as have been reported with Avandia side effects.  However, many officials are questioning the ethics of this sort of one-on-one study, and some are beginning to call for a halt to the study and for a full Avandia recall.

The reason for ethical concerns is that studies need subjects to take part in them, and the TIDE study could prove to be dangerous for those who are involved and taking Avandia as part of the ongoing research.  Basically, some are beginning to wonder if the study, which began in 2007, is worth the risk that the subjects are encountering.  Reports indicate that if the study is ended, it could lead to the next logical step of an Avandia recall.

If you or someone you love has used this medication and have suffered as a result, you need to take action by contacting an Avandia side effects lawyer who understands what it takes to hold enormous corporations accountable for the defective drugs they release onto the marketplace.  Contact Atkins & Markoff today to schedule a free initial consultation.